Article
Eli Lilly easily tops quarterly estimates, raises outlook as Zepbound and Mounjaro sales surge
Strong Bullish
91.9
−100 Bearish
0
+100 Bullish
Eli Lilly now expects 2026 revenue to come in between $85 billion and $87 billion, up from a previous guidance of $82 billion and $85 billion.
Actions
Pulse AI
Pulse analysis not available yet. Click "Get Pulse" above.
Generated by Pulse AI, Glideslope's proprietary engine for interpreting market sentiment and economic signals. For informational purposes only — not financial advice.
Article Info
Sentiment Signal
Strong Bullish
91.9
−100Neutral+100
More Like This